Thermo Fisher launches centrifugation BioProcess Container for closed-system handling of critical sterile liquids
The Thermo Scientific CentriPAK BPC offers sample protection from contamination and enhanced laboratory productivity
The Thermo Scientific CentriPAK BPC offers sample protection from contamination and enhanced laboratory productivity
Niton XL5 Plus, the smallest and lightest handheld XRF analyzer available, delivers unprecedented performance and accuracy
Innovative platform ensures traceability of materials research images, data, metadata and experimental workflows
The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases
Subsidized technology available as global bodies call for sequencing to confirm COVID-19 mutations
The acquisition will offer greater flow cytometry and imaging multiplexing capabilities to meet needs in protein and cell analysis research
The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic
The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens
The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients
The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts
Thermo Scientific Tox Explorer Collection provides instruments, columns and consumables with reliable and validated methods for reproducible results
Program will leverage Ion Torrent Genexus System and Oncomine Precision Assay to advance precision medicine for lung cancer in Asia
The company will increase production of pipette and automation tips, storage tubes and plates, transfer pipettes, and packaging for vials and bottles
Agreements with AstraZeneca and the University of Nebraska Medical Center showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis
This makes the Oncomine Dx Target Test the first NGS-based companion diagnostic for RET fusion-positive NSCLC and expands the test’s utility
CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO